Is There a Role for Liver Transplantation in Metastatic Pancreatic Neuroendocrine Tumors (PNET)?
DOI:
https://doi.org/10.6092/1590-8577/819Keywords:
Chemoradiotherapy, General Surgery Neoplasm Metastasis, Neuroendocrine Tumors, Pancreas, TransplantationDownloads
References
Saif MW, Ng J, Chang B, Russo S. Is There a Role of Radiotherapy in the Management of Pancreatic Neuroendocrine Tumors (PNET)? JOP. 2012 Mar 10;13(2):174-6.
Bertram W. Maidment, Trevor Ellison, Joseph M. Herman, Navesh K Sharma, Dan Laheru, William Regine, et al. Radiation in the management of pancreatic neuroendocrine tumors. J Clin Oncol 30, 2012 (suppl 4; abstr 335).
Moertel CG, Lefkopoulo M, et al. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozoticin in the treatment of advanced islet-cell carcinoma. N Engl J Med. 1992;326:519-523.
Norton, JA, Warren RS, Kelly MC, Zuraek MB, Jensen RT. Aggressive surgery for metastatic neuroendocrine tumors. Surgery. 2003; 134:1057-1065.
Sarmiento, JM and Que FG. Hepatic Surgery for metastases from neuroendocrine tumors. Surg Oncol Clin N Am. 2003 Jan;12(1):231-242.
Lehnert, T. Liver Transplantation for metastatic neuroendocrine carcinoma: An analysis of 103 patients. Transplantation. 1998;66(10); 1307-1312
Rosenau J, Bahr MJ, et al. Ki67, E-cadherin, and p53 as prognostic indicators of long termoutcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation. 2002; 17(3):386-394
Coppa J, Pulvirent A, et al. Resection versus transplantation for liver metastases from neuroendocrine tumors. Transpl Proc 2001; 33: 1537-1539.
